Long-term prognosis of left ventricular re-remodeling after surgery of ischemic cardiomyopathy: the potential of tomographic radionuclide ventriculography

Aim. To assess the potential of stress tomographic radionuclide ventriculography (T-RVG) in long-term prognosis of left ventricular (LV) re-remodeling after surgery of ischemic cardiomyopathy.
Material and methods. Thirty patients with ischemic cardiomyopathy, before surgical treatment, underwent resting T-RVG and with increasing doses of dopamine (5/10/15 pg/kg/min (5 min/dose). All patients underwent two-dimensional echocardiography before surgery, in the short- (7-14 days) and long-term postoperative period. In the long-term postoperative period (476±36 days), the patients were divided into two groups: group 1 (n=19) — patients with ongoing LV remodeling (increase in the LV end-systolic volume (ESV) or decrease <10% relatively short-term postoperative period), group 2 (n=11) — patients with decreased LV ESV >10%.
Results. The results revealed significant differences between the groups in the dynamics (Δ) of the LV ejection fraction (EF) (%) (2 (2;8); 11 (5;12), p=0,02), peak ejection rate (%) (32 (14;51); 63 (34;79), p=0,009), LV dyssynchrony (PSD^o (3 (0;7); -2 (-9;3), p=0,004); Entropy (%) (2 (-1;6); 0 (-4;2), p=0,01)). Univariate regression showed that ΔLVEF (odds ratio (OR), 0,88; confidence interval (CI), 0,8; 0,97; p=0.008), ΔLVPSD (OR, 1,13; CI, 1,03; 1,25; p=0,005), and coronary stenosis >75% (OR, 4,25; CI, 1,57; 11,48; p=0,001) had a predictive value. According to the ROC-analysis, the sensitivity, specificity, and AUC were 87%, 64% and 0,727 for ΔLVPSD (threshold >-1); 84%, 46% and 0,691 for coronary stenosis >75% >75% (threshold >2); 65%, 82% and 0,674 for ΔLVEF (threshold ≤4), respectively. The logistic model, which included these parameters and the presence of diabetes, showed a significantly greater AUC (0,907, p<0,05) compared with these indicators taken separately.
Conclusion. Preoperative values of ΔLVEF and ΔLVPSD obtained with stress T-RVG have prognostic significance in relation to LV long-term re-remodeling.

1. Patel P, Ivanov A, Ramasubbu K. Myocardial Viability and Revascularization: Current Understanding and Future Directions. Current Atherosclerosis Reports. 2016;18(6):32. doi:10.1007/s11883-016-0582-5.

2. Shipulin VV, Saushkin VV, Pryakhin AS, et al. The value of myocardium perfusion imaging in assessment of patients with ischemic cardiomyopathy. REJR. 2019;9(3):155-75. (In Russ.) doi:10.21569/2222-7415-2019-9-3-155-175.

3. Shipulin VM, Pryakhin AS, Andreev SL, et al. Surgical Treatment of Ischemic Cardiomyopathy: Current State of the Problem. Kardiologiia. 2019;59(9):71-82. (In Russ.) doi:10.18087//cardio.2019.9.n329.

4. Mele D, Bertini M, Malagi M, et al. Current role of echocardiography in cardiac resynchronization therapy. Heart Fail Rev. 2017;22(6):699-722. doi:10.1007/s10741-017-9636-1.

5. Romero-Farina G, Aguade-Bruix S. Equilibrium radionuclide angiography: Present and future. Journal of Nuclear Cardiology. 2019. doi:10.1007/s12350-019-01876-9.

6. van Dijk JD. Dose-optimization in nuclear cardiac imaging, time for the next step? J Nucl Cardiol. 2019;26(6):1981-3. doi:10.1007/s12350-018-1441-2.

7. Zavadovskiy KV, Saushkin VV, Pankova AN, et al. Methodological features of gated blood pool spect data acquisition, imaging processing and results interpretation. Radiology — Practice. 2011;6:75-83. (In Russ.)

8. Henzlova MJ, Duvall WL, Einstein AJ, et al. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers. J Nucl Cardiol. 2016;23(3):606-45. doi:10.1007/s12350-015-0387-x.

9. Gauthey A, Willemen E, Lumens J, et al. Impact of paced left ventricular dyssynchrony on left ventricular reverse remodeling after cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2020;31(2):494-502. doi:10.1111/jce.14330.

10. Loffler AI, Kramer CM. Myocardial Viability Testing to Guide Coronary Revascularization. Interv Cardiol Clin. 2018;7(3):355-65. doi:10.1016/j.iccl.2018.03.005.

11. Skala T, Hutyra M, Vaclavik J, et al. Prediction of long-term reverse left ventricular remodeling after revascularization or medical treatment in patients with ischemic cardiomyopathy: a comparative study between SPECT and MRI. The International Journal of Cardiovascular Imaging. 2010;27(3):343-53. doi:10.1007/s10554-010-9677-1.

12. Zavadovsky KV, Gulya MO, Lishmanov YB, et al. Perfusion and metabolic scintigraphy with 123I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy. Ann Nucl Med. 2016;30(5):325-33. doi:10.1007/s12149-016-1064-0.

13. Park S, Cheon GJ, Paeng JC, et al. Phase analysis of gated myocardial perfusion singlephoton emission computed tomography after coronary artery bypass graft surgery: reflection of late reverse remodeling in patients with patent grafts after coronary artery bypass graft surgery. Nucl Med Commun. 2016;37(11):1139-47. doi:10.1097/MNM.0000000000000565.

14. Wei H, Tian C, Schindler TH, et al. The impacts of severe perfusion defects, akinetic/ dyskinetic segments, and viable myocardium on the accuracy of volumes and LVEF measured by gated 99mTc-MIBI SPECT and gated 18F-FDG PET in patients with left ventricular aneurysm: cardiac magnetic resonance imaging as the reference. J Nucl Cardiol. 2014;21(6):1230-44. doi:10.1007/s12350-014-9978-1.